000 01379 a2200301 4500
005 20250515060619.0
264 0 _c20070731
008 200707s 0 0 eng d
022 _a1600-6135
024 7 _a10.1111/j.1600-6143.2007.01738.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRyan, C M
245 0 0 _aclinical research, innovative practice and IRB review: identifying and respecting boundaries.
_h[electronic resource]
260 _bAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
_cApr 2007
300 _a748-50 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aDrug Administration Schedule
650 0 4 _aHumans
650 0 4 _aImmunosuppression Therapy
_xtrends
650 0 4 _aImmunosuppressive Agents
_xstandards
650 0 4 _aTacrolimus
_xtherapeutic use
650 0 4 _aTransplantation Immunology
_xphysiology
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aSwanson, D P
773 0 _tAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
_gvol. 7
_gno. 4
_gp. 748-50
856 4 0 _uhttps://doi.org/10.1111/j.1600-6143.2007.01738.x
_zAvailable from publisher's website
999 _c16888478
_d16888478